New tuberculosis (TB) vaccines in development have the potential to provide protection against all strains of TB, including multidrug-resistant (MDR) and extensively drug- resistant (XDR) TB, Dr. Jerald C. Sadoff, president and CEO of the Aeras Global TB Vaccine Foundation, said here today at the International Conference on Global Health. [click link for full article]
More...